BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PBX1
,
calcium channel activity
,
Influenza
,
Lymphocyte
,
Alcohol
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
persistent hematuria
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Abdominal aortae of Brown Norway rats with pathophysiological phenotypes involving arteries
Explore Curated Studies Results
Literature
Most Relevant Literature
Persistent asymptomatic isolated hematuria in children: clinical and histopathological features and …
Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission:…
Hemorrhagic Cystitis: Making Rapid and Shrewd Clinical and Surgical Decisions for Improving Patient …
Metastatic bladder cancer presenting with persistent hematuria in young man with cystic fibrosis.
Persistent haematuria and proteinuria due to glomerular disease in related Abyssinian cats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vaginal Estrogen for Asymptomatic Microscopic Hematuria
Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population
Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With…
Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ